AI in Health Care Series
Health care is entering a transformative period.

With the sector under pressure to improve patient outcomes while controlling costs, artificial intelligence and machine learning are quickly becoming indispensable tools. These technologies show promise for supporting decision-making, enhancing the delivery of care, and personalizing medicine, while also revolutionizing medical research by giving scientists access to unprecedented amounts of data that could lead to novel treatments or cures for diseases.
To help navigate this dynamic era, Foley has launched its AI in Health Care Series to guide health care organizations deploying AI-based solutions. Our contributors will examine this intersection through lenses including its impact on merger activity, antitrust enforcement, patent prosecution, and more.
Co-Editors
AI in Health Care Series Insights
12 search results for:
AI in Health Care Series

AI Drug Development: FDA Releases Draft Guidance

AI in Drug Discovery: 2025 Outlook

Patenting Power Plays For AI Drug Discovery

Leveraging Risk Management Frameworks for AI Solutions in Health Care

Safeguarding AI Innovation in Stem Cell Therapy

IP Toolbox Is Crucial In AI-Powered Drug Discovery

AI in Health Care: Regulatory Landscape & Risk Mitigation

Sequencing the Impact: How AI is Boosting Genomic Medicine
